Literature DB >> 24024860

Case reports of PML in patients treated for psoriasis.

Ummehan Ermis, Joachim Weis, Jörg B Schulz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24024860     DOI： 10.1056/NEJMc1307680

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

2.  The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Authors:  Luisa J Ströh; Melissa S Maginnis; Bärbel S Blaum; Christian D S Nelson; Ursula Neu; Gretchen V Gee; Bethany A O'Hara; Nasim Motamedi; Daniel DiMaio; Walter J Atwood; Thilo Stehle
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  ERK Is a Critical Regulator of JC Polyomavirus Infection.

Authors:  Jeanne K DuShane; Michael P Wilczek; Colleen L Mayberry; Melissa S Maginnis
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.

Authors:  A H Cross; L Piccio; E E Longbrake; M J Ramsbottom; C Cantoni; L Ghezzi
Journal:  Mult Scler       Date:  2015-10-12       Impact factor: 6.312

5.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

Review 6.  Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.

Authors:  Rebecca S Farber; Ilana K Sand
Journal:  Ther Adv Neurol Disord       Date:  2015-09       Impact factor: 6.570

Review 7.  Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.

Authors:  S Richard Dunham; Robert Schmidt; David B Clifford
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.